Filters
on 09 Aug 2022
SyneuRx International (Taiwan) Corp
88031647 · 10 Jul 2018
09 Aug 2028
005
Class 005
Pharmaceutical Products
Therapeutic pharmaceutical for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; chemical preparations for pharmaceutical or medical purposes, namely, for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; chemical reagents for medical or veterinary purposes, excluding reagents for use in development of skin care products or cosmetics; antibacterial substances for medical purposes, excluding antibacterial substances for use in skin care products or cosmetics; amino acid preparations for medical purposes, excluding amino acid preparations for use in skin care products or cosmetics; amino acids for medical or veterinary purposes, excluding amino acids for use in skin care products or cosmetics; amino acids for medical purposes, excluding amino acids for use in skin care products or cosmetics
Therapeutic pharmaceutical for the treatment of neuropsychiatric disor...
on 31 Aug 2021
SyneuRx International (Taiwan) Corp.
90067787 · 22 Jul 2020
31 Aug 2027
005
Class 005
Pharmaceutical Products
Acids for pharmaceutical purposes, namely, aromatic acids for the treatment of viral infection; antibiotics; viral antibiotics; cachets for pharmaceutical purposes, namely, cachets filled with aromatic acids for the treatment of viral infection; cachou for pharmaceutical purposes, namely, cachou filled with aromatic acids for the treatment of viral infection; candy, medicated; candy for medical purposes; capsules filled with aromatic acids for the treatment of viral infection; chemical preparations for pharmaceutical purposes for the treatment of viral infection; chemical preparations for medical purposes for the treatment of viral infection; chemical preparations for veterinary purposes for the treatment of viral infection; chemical reagents for medical or veterinary purposes; chemico-pharmaceutical preparations for the treatment of viral infection; chewing gum for medical purposes; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; dietetic injection and dietetic infusion adapted for medical use; drugs for medical purposes for the treatment of viral infection; flour for pharmaceutical purposes; meal for pharmaceutical purposes; freeze-dried food adapted for medical purposes; lyophilized food adapted for medical purposes; germicides; gum for medical purposes for the treatment of viral infection; homogenized food adapted for medical purposes; medicated animal feed; medicated dentifrices; medicinal infusions for the treatment of viral infection; medicines for human purposes for treatment of viral infection; medicines for veterinary purposes for treatment of viral infection; preparations being cultures of microorganisms for medical or veterinary use; nervines; nutraceutical preparations for treatment of viral infection; nutritional supplements; ointments for treatment of viral infection; cough pastilles for pharmaceutical purposes; cough lozenges for pharmaceutical purposes; pectin for pharmaceutical purposes for treatment of viral infection; pharmaceutical preparations for treatment of viral infection; pharmaceuticals for treatment of viral infection; poultices; pre-filled syringes filled with aromatic acids for the treatment of viral infection; aromatic acid salts for the treatment of viral infection; sedatives; tranquillizers; suppositories for treatment of viral infection; syrups for pharmaceutical purposes for treatment of viral infection; medicated tonics for the treatment of viral infection; inhalation devices, namely, inhalers filled with aromatic acids for the treatment of viral infection; drugs for pulmonary administration for the treatment of viral infection
Acids for pharmaceutical purposes, namely, aromatic acids for the trea...
on 18 May 2021
SyneuRx International (Taiwan) Corp.
88167507 · 24 Oct 2018
18 May 2027
005
Class 005
Pharmaceutical Products
Syrups for pharmaceutical purposes for the treatment of Hyperglycemia, diabetes, prediabetes, insulin resistance, diabetic ketoacidosis (DKA), hyperglycemic hyperosmolar nonketotic syndrome (HHNS), Hyperthyroidism, Polyphagia, polydipsia, polyuria, glycosuria, increased thirst and a frequent need to Urinate, coma, abdominal pain, poor wound healing, Stomach and intestinal problems such as chronic constipation or diarrhea, Worse vision, Damage to eyes, blood vessels, or kidneys, hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, obesity, hypertension, heart disease, heart attack, stroke, thrombosis, fatty liver, liver cirrhosis, hyperuricemia, gout, pain in joints, joint stiffness, redness and swelling, Autism, Asperger's disorder, panic disorder, post-traumatic stress disorder, pain, childhood learning disorder, attention deficit hyperactivity disorder (ADHD), Tourette's syndrome, mania, obsessive compulsive disorder, and other diseases or symptoms related to CNS disorder, metabolic disorder, or diabetes; Pharmaceutical preparations for the treatment of Hyperglycemia, diabetes, prediabetes, insulin resistance, diabetic ketoacidosis (DKA), hyperglycemic hyperosmolar nonketotic syndrome (HHNS), Hyperthyroidism, Polyphagia, polydipsia, polyuria, glycosuria, increased thirst and a frequent need to Urinate, coma, abdominal pain, poor wound healing, Stomach and intestinal problems such as chronic constipation or diarrhea, Worse vision, Damage to eyes, blood vessels, or kidneys, hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, obesity, hypertension, heart disease, heart attack, stroke, thrombosis, fatty liver, liver cirrhosis, hyperuricemia, gout, pain in joints, joint stiffness, redness and swelling, Autism, Asperger's disorder, panic disorder, post-traumatic stress disorder, pain, childhood learning disorder, attention deficit hyperactivity disorder (ADHD), Tourette's syndrome, mania, obsessive compulsive disorder, and other diseases or symptoms related to CNS disorder, metabolic disorder, or diabetes; Pharmaceutical preparations for the treatment and prevention of Hyperglycemia, diabetes, prediabetes, insulin resistance, diabetic ketoacidosis (DKA), hyperglycemic hyperosmolar nonketotic syndrome (HHNS), Hyperthyroidism, Polyphagia, polydipsia, polyuria, glycosuria, increased thirst and a frequent need to Urinate, coma, abdominal pain, poor wound healing, Stomach and intestinal problems such as chronic constipation or diarrhea, Worse vision, Damage to eyes, blood vessels, or kidneys, hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, obesity, hypertension, heart disease, heart attack, stroke, thrombosis, fatty liver, liver cirrhosis, hyperuricemia, gout, pain in joints, joint stiffness, redness and swelling, Autism, Asperger's disorder, panic disorder, post-traumatic stress disorder, pain, childhood learning disorder, attention deficit hyperactivity disorder (ADHD), Tourette's syndrome, mania, obsessive compulsive disorder, and other diseases or symptoms related to CNS disorder, metabolic disorder, or diabetes; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Transdermal patches for use in the treatment of Hyperglycemia, diabetes, prediabetes, insulin resistance, diabetic ketoacidosis (DKA), hyperglycemic hyperosmolar nonketotic syndrome (HHNS), Hyperthyroidism, Polyphagia, polydipsia, polyuria, glycosuria, increased thirst and a frequent need to Urinate, coma, abdominal pain, poor wound healing, Stomach and intestinal problems such as chronic constipation or diarrhea, Worse vision, Damage to eyes, blood vessels, or kidneys, hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, obesity, hypertension, heart disease, heart attack, stroke, thrombosis, fatty liver, liver cirrhosis, hyperuricemia, gout, pain in joints, joint stiffness, redness and swelling, Autism, Asperger's disorder, panic disorder, post-traumatic stress disorder, pain, childhood learning disorder, attention deficit hyperactivity disorder (ADHD), Tourette's syndrome, mania, obsessive compulsive disorder, and other diseases or symptoms related to CNS disorder, metabolic disorder, or diabetes; Natural dietary supplements for the treatment of Hyperglycemia, diabetes, prediabetes, insulin resistance, diabetic ketoacidosis (DKA), hyperglycemic hyperosmolar nonketotic syndrome (HHNS), Hyperthyroidism, Polyphagia, polydipsia, polyuria, glycosuria, increased thirst and a frequent need to Urinate, coma, abdominal pain, poor wound healing, Stomach and intestinal problems such as chronic constipation or diarrhea, Worse vision, Damage to eyes, blood vessels, or kidneys, hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, obesity, hypertension, heart disease, heart attack, stroke, thrombosis, fatty liver, liver cirrhosis, hyperuricemia, gout, pain in joints, joint stiffness, redness and swelling, Autism, Asperger's disorder, panic disorder, post-traumatic stress disorder, pain, childhood learning disorder, attention deficit hyperactivity disorder (ADHD), Tourette's syndrome, mania, obsessive compulsive disorder, and other diseases or symptoms related to CNS disorder, metabolic disorder, or diabetes
Syrups for pharmaceutical purposes for the treatment of Hyperglycemia,...
on 30 Mar 2021
SyneuRx International (Taiwan) Corp
88031657 · 10 Jul 2018
30 Mar 2027
005
Class 005
Pharmaceutical Products
Therapeutic pharmaceutical for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Chemical preparations for pharmaceutical or medical purposes, namely, for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Chemical reagents for medical or veterinary purposes; Antibacterial substances for medical purposes; Amino acid preparations for medical purposes; Amino acids for medical or veterinary purposes; Amino acids for medical purposes
Therapeutic pharmaceutical for the treatment of neuropsychiatric disor...
on 30 Mar 2021
SyneuRx International (Taiwan) Corp.
87914101 · 09 May 2018
30 Mar 2027
005
Class 005
Pharmaceutical Products
Therapeutic pharmaceutical for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Syrups for pharmaceutical purposes for the treatment of ADHD; Chemical preparations for pharmaceutical or medical purposes, namely, for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Chemical reagents for medical or veterinary purposes; Adjuvants for medical purposes; Animal feed additive for use as a nutritional supplement for medical purposes; Amino acid preparations for medical purposes; Amino acids for medical or veterinary purposes; Amino acids for medical purposes; Beverages containing amino acid for use as a nutritional supplement; Liquid nutritional supplement; Amino acids for nutritional purposes; Dietary and nutritional supplements; Nutritional supplements in the form of capsules, tablets, caplets, powder, syrups, gummies and gels; Powdered nutritional supplement drink mix; Nutritional supplement meal replacement bars for boosting energy; Nutritional supplements consisting primarily of amino acid; Nutritional supplement shakes; Nutritional and dietary supplements formed and packaged as bars; Nutritional supplements in capsule form for dogs; Nutritional supplements; Nutritionally fortified water for medical purposes; Nutritionally fortified beverages for medical purposes; Vitamin fortified beverages for medical purposes; Vitamin enriched chewing gum for medical purposes; Soy protein for use as a nutritional supplement in various powdered and ready-to-drink beverages; Nutritional supplement in the nature of a nutrient-dense, protein-based drink mix; Powdered nutritional supplement drink mix containing amino acid; Nutritional supplements for cats, dogs; Nutraceuticals for use as a dietary supplement for depressed mood; Nutraceuticals for the treatment of CNS disorders; Nutraceuticals for use as a dietary supplement
Therapeutic pharmaceutical for the treatment of neuropsychiatric disor...
on 30 Mar 2021
SyneuRx International (Taiwan) Corp.
87914117 · 09 May 2018
30 Mar 2027
005
Class 005
Pharmaceutical Products
Therapeutic pharmaceutical for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Phenol for pharmaceutical purposes; Plant extracts for medical, veterinary and pharmaceutical purposes; Syrups for pharmaceutical purposes for the treatment of dementia; Chemical preparations for pharmaceutical or medical purposes, namely, for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Plant extracts for pharmaceutical purposes; Pharmaceutical preparations for treating sunburn; Chemical reagents for medical or veterinary purposes; Adjuvants for medical purposes; Animal feed additive for use as a nutritional supplement for medical purposes; Medicinal herbal extracts for medical purposes; Antibacterial substances for medical purposes; Transdermal patches featuring medication for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Nutritional food additives for medical purposes in the nature of natural food extracts derived from plant; Herbal extracts for medical purposes; Phytotherapy preparations for medical purposes; Appetite suppressants for medical purposes; Beverages containing tannic acid for use as a nutritional supplement; Liquid nutritional supplement; Dietary and nutritional supplements; Nutritional supplements in the form of capsules, tablets, caplets, powder, syrups, gummies and gels; Powdered nutritional supplement drink mix; Nutritional supplement meal replacement bars for boosting energy; Nutritional supplements consisting primarily of tannic acid; Dietary and nutritional supplements used for weight loss; Nutritional supplement shakes; Nutritional and dietary supplements formed and packaged as bars; Nutritional supplements in capsule form for dogs; Nutritional supplements; Nutritional supplement for eliminating toxins from the body; Nutritionally fortified water for medical purposes; Nutritionally fortified beverages for medical purposes; Vitamin fortified beverages for medical purposes; Vitamin enriched chewing gum for medical purposes; Soy protein for use as a nutritional supplement in various powdered and ready-to-drink beverages; Nutritional supplement in the nature of a nutrient-dense, protein-based drink mix; Powdered nutritional supplement drink mix containing tannic acid; Nutritional supplements for cats, dogs; Nutraceuticals for use as a dietary supplement for cognitive impairment; Nutraceuticals for the treatment of CNS disorders; Nutraceuticals for use as a dietary supplement
Therapeutic pharmaceutical for the treatment of neuropsychiatric disor...
on 30 Mar 2021
SyneuRx International (Taiwan) Corp.
87914130 · 09 May 2018
30 Mar 2027
005
Class 005
Pharmaceutical Products
Therapeutic pharmaceutical for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Chemical preparations for pharmaceutical or medical purposes, namely, for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Chemical reagents for medical or veterinary purposes; Sodium salts for medical purposes
Therapeutic pharmaceutical for the treatment of neuropsychiatric disor...
on 30 Mar 2021
SyneuRx International (Taiwan) Corp
87953269 · 07 Jun 2018
30 Mar 2027
005
Class 005
Pharmaceutical Products
Therapeutic pharmaceutical for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Chemical preparations for pharmaceutical or medical purposes, namely, for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Chemical reagents for medical or veterinary purposes; Antibacterial substances for medical purposes; Amino acid preparations for medical purposes; Amino acids for medical or veterinary purposes; Amino acids for medical purposes
Therapeutic pharmaceutical for the treatment of neuropsychiatric disor...
on 23 Feb 2021
SyneuRx International (Taiwan) Corp.
88087944 · 22 Aug 2018
23 Feb 2027
005
Class 005
Pharmaceutical Products
Therapeutic pharmaceutical for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Chemical preparations for pharmaceutical or medical purposes, namely, for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Chemical reagents for medical or veterinary purposes; Sodium salts for medical purposes
Therapeutic pharmaceutical for the treatment of neuropsychiatric disor...
on 01 Apr 2024
SyneuRx International (Taiwan) Corp.
97125105 · 15 Nov 2021
005
Class 005
Pharmaceutical Products
Antiviral drugs; antibiotics; antibiotics for animals; chemical reagent for medical purposes; chemical reagent for veterinary purposes; germicides for animals; germicides; biocides for medical purposes; germicide for human use; biocides for veterinary purposes; medicines for human purposes namely, for treatment of virus infection, neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, hyperactivity, anxiety, bipolar disorder, and other central nervous system disorders; medicines for human purposes namely, for improving basic behavioral functioning, suicidal ideation and behavior, sensorimotor gating, pain threshold, memory and cognitive functioning and loss weight; sedatives; nervines for pharmaceutical or medical purposes, namely, for treating attention deficit hyperactivity disorder (ADHD), schizophrenia, pain, depression, bipolar disorder, eating disorder, addiction disorder, personality disorder, psychotic disorder, tic disorder, post-traumatic stress disorder, anxiety, social anxiety disorder, panic disorder, autism, Asperger's disorder, obsessive-compulsive disorder (OCD), learning disorder, Tourette's syndrome, mild cognitive disorder (MCI), benign forgetfulness, closed head injury, dementia, vascular dementia, Alzheimer's disorder, frontotemporal dementia, Parkinson's disorder, Huntington's disease, nocturnal enuresis, blepharospasm, non-epileptic seizure, premenstrual syndrome, and amyotrophic lateral sclerosis (ALS); gases for pharmaceutical or medical purposes, namely, for treating attention deficit hyperactivity disorder (ADHD), schizophrenia, pain, depression, bipolar disorder, eating disorder, addiction disorder, personality disorder, psychotic disorder, tic disorder, post-traumatic stress disorder, anxiety, social anxiety disorder, panic disorder, autism, Asperger's disorder, obsessive-compulsive disorder (OCD), learning disorder, Tourette's syndrome, mild cognitive disorder (MCI), benign forgetfulness, closed head injury, dementia, vascular dementia, Alzheimer's disorder, frontotemporal dementia, Parkinson's disorder, Huntington's disease, nocturnal enuresis, blepharospasm, non-epileptic seizure, premenstrual syndrome, and amyotrophic lateral sclerosis (ALS);nasal spray for treating respiratory tract infections caused by viruses or bacteria; oral spray for treating respiratory tract infections caused by viruses or bacteria
Antiviral drugs; antibiotics; antibiotics for animals; chemical reagen...
AI Trademark Registrability
Image Search
Drag and drop or upload to search any image
End of search results
Page 1 of 1